Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing

Many preclinical studies have shown that birth-associated tissues, cells and their secreted factors, otherwise known as perinatal derivatives (PnD), possess various biological properties that make them suitable therapeutic candidates for the treatment of numerous pathological conditions. Nevertheles...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aleksandar Janev, Asmita Banerjee, Adelheid Weidinger, Jure Dimec, Brane Leskošek, Antonietta Rosa Silini, Tina Cirman, Susanne Wolbank, Taja Železnik Ramuta, Urška Dragin Jerman, Assunta Pandolfi, Roberta Di Pietro, Michela Pozzobon, Bernd Giebel, Günther Eissner, Polonca Ferk, Ingrid Lang-Olip, Francesco Alviano, Olga Soritau, Ornella Parolini, Mateja Erdani Kreft
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-11-01
Col·lecció:	Frontiers in Bioengineering and Biotechnology
Matèries:	standardization perinatal derivatives recommendations CA17116 (SPRINT) PnD e-questionnaire
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fbioe.2023.1258753/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!